IRLEN FERNANDEZ: Open Payments
NPI 1881214476 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,862 in 96 payments from 17 companies in 2025. Trend: 2023 $1,141 · 2024 $1,808 · 2025 $1,862
Food & beverage: $1,862
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $444 |
| Madrigal Pharmaceuticals | 10 | $289 |
| Ipsen Biopharmaceuticals, Inc | 12 | $253 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $187 |
| Intercept Pharmaceuticals, Inc. | 8 | $161 |
| Ardelyx, Inc. | 9 | $138 |
| Phathom Pharmaceuticals, Inc. | 5 | $89 |
| Gilead Sciences, Inc. | 2 | $69 |
| Janssen Biotech, Inc. | 3 | $57 |
| Novo Nordisk Inc | 2 | $50 |
Products named: REZDIFFRA, IQIRVO, XIFAXAN, OCALIVA, CREON, SKYRIZI, IBSRELA, LINZESS.
Industry payments across FL — which companies pay providers there.
